Background {#Sec1}
==========

Infectious diseases are the leading causes of morbidity and death in India \[[@CR1]\]. Field studies on fever aetiology in India are few, and surveillance is limited by lack of accessibility to health facilities. The wide uncertainty range is illustrated by the gap between approximately 1000 malaria deaths per year reported annually from India and estimated numbers between 20,000 and 200,000 per year \[[@CR2]--[@CR4]\]. In acute undifferentiated fever (AUF), symptoms are unspecific, and if accurate diagnostic methods are not available, empirical treatment needs to be broad in order to avoid deaths. Prevalence data and access to affordable, sensitive and specific diagnostic methods are tools to provide targeted and effective treatment of severe acute infections, and to avoid further development of antimicrobial resistance in India \[[@CR5]\]. However, multiple positive diagnostic test results in the same patient are common, as shown by D'Acremont et al. in a study in Tanzania \[[@CR6]\]. Positive tests due to subclinical or previous infections and cross reactivity in serological tests, makes interpretation of results a challenge. Awareness of the limitations and strengths of diagnostic tests is necessary both in the interpretation of epidemiological surveys and when approaching the individual fever patient.

The main objective of this study was to determine the proportion of AUF caused by malaria, bacteraemia, scrub typhus, leptospirosis, chikungunya and dengue among patients admitted to community hospitals in India. A secondary objective was to describe the performance of routine diagnostic methods.

Methods {#Sec2}
=======

Study sites and participants {#Sec3}
----------------------------

During April 2011--November 2012, patients aged ≥5 years admitted with AUF were consecutively included from the following secondary, community (100 to 500) bed hospitals: Baptist Christian Hospital in Tezpur (Assam, North East India), Duncan Hospital in Raxaul (Bihar, North India), Christian Hospital in Mungeli (Chhattisgarh, Central India), B.K. Walawalkar Hospital in Ratnagiri (Maharashtra, Western India), Rural Development Trust Hospital in Anantapur (Andhra Pradesh, South India), Christian Fellowship Hospital in Oddanchatram (Tamil Nadu, South India) and Bethesda Hospital in Ambur (Tamil Nadu, South India) (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Location of hospitals in six states of India participating in the study

Details of the climate variation among the study sites have been published previously \[[@CR7]\]. The study coordinating centre was Christian Medical College (CMC), Vellore, India.

AUF was defined as measured temperature ≥ 38 °C and history of febrile illness of 2--14 days duration, with no localized cause as judged by the treating physician. Patients were not excluded if they had abdominal pain, diarrhoea, haematochezia, nausea or vomiting, rhinorrhoea, dyspnoea, ocular pain, altered sensorium, headache, stiff neck, rash, arthralgia, myalgia, petechiae, ecchymosis, epistaxis, gingival bleeding or jaundice.

Study procedures {#Sec4}
----------------

### Microbiological investigations {#Sec5}

The following laboratory tests were performed at the study hospitals as part of routine investigation: Malaria blood smears, Scrub typhus IgM ELISA (In Bios, USA), *Leptospira* IgM ELISA (Panbio Pty., Ltd., Queensland, Australia), Chikungunya IgM ELISA (NIV, India), Dengue rapid NS1 antigen and IgM/IgG Combo test (SD bioline, USA) and blood cultures. Convalescence serology testing was not performed due to logistic challenges. In order to improve detection of IgM antibodies serological testing was delayed until five days of fever, if possible.

Blood was cultured with conventional methods, or automated (BACTEC, Becton Dickinson, Maryland, USA), and if growth was detected, the isolate was identified at each site and frozen, then in Transport swab (Hi Media, Mumbai, India) sent to the reference laboratory for re-identification and confirmation.

The following investigations were performed at the reference laboratory at CMC: Scrub typhus IgM ELISA (cut off value of 0.5 OD), *Leptospira* IgM ELISA, Chikungunya IgM ELISA and Dengue NS1/IgM Combo test, only if not performed at local site. Dengue IgM capture ELISA (MAC-ELISA) was performed at reference laboratory on all samples. Scrub typhus immunofluorescence (IFA) was performed on all IgM ELISA positives and some ELISA negatives. *Leptospira* Microscopic Agglutination Test (MAT) was performed on all IgM ELISA positives and some ELISA negatives.

The immunochromatographic malaria rapid diagnostic test (RDT) Parahit Total™ (Span Diagnostics Ltd., Surat, India) was performed on all samples. A *Plasmodium* genus-specific PCR targeting mitochondrial genome \[[@CR8]\] was performed on all samples, and a species-specific PCR targeting 18S or sequencing was performed to identify species on those that were genus PCR positive. Details on the malaria diagnostic methods and results in this study have been reported previously \[[@CR7]\].

Case definitions were as follows:

Leptospirosis: Positive ELISA and positive MAT.

Scrub typhus: Positive ELISA and positive IFA.

Dengue: Positive RDT and/or positive MAC-ELISA.

Chikungunya: Positive ELISA.

Bacteraemia: Growth of bacteria not considered to be contaminants in blood culture.

Malaria: Positive malaria genus-specific PCR.

All tests were performed as per the standard protocol provided by the manufacturers. Some serology tests were performed as a quality control with the same method both at the local centre and at the reference laboratory. In these cases a positive result was defined as two positive results or one positive and one equivocal, a negative result defined as two negatives or one negative and one equivocal, while one positive and one negative result was defined as discrepant.

Statistical analysis {#Sec6}
--------------------

Chi-square test was used to assess differences between proportions.

Results {#Sec7}
=======

A total of 1564 patients were included, with mean (median, range) age 34 (31, 5--105) years. Among these 632 (40%) were women and 895 (57%) were men, and 1219 (78%) lived in rural areas. Table [1](#Tab1){ref-type="table"} shows demographic characteristics for each study site.Table 1Demographic characteristics. *N* = 1564CharacteristicsTotalOddanchatramAmburTezpurMungeliAnantapurRatnagiriRaxaulPatients N (%)1564 (100)330 (21)316 (20)336 (22)62 (4)160 (10)251 (16)109 (7)Gender N (%) Female632 (40)154 (47)139 (45)135 (41)25 (48)42 (28)96 (38)41 (39) Male895 (57)176 (53)170 (55)195 (59)27 (52)108 (72)154 (62)65 (61)Age (years) mean/median/range34/31/5--10532/31/5--8435/32/5--8534/30/5--8833/27/6--9030/30/5--8538/36/10--8529/26/6--105Residency N (%) Urban276 (18)57 (17)107 (37)25 (8)8 (15)35 (24)39 (16)5 (5) Rural1219 (78)271 (83)186 (64)294 (92)44 (85)113 (76)209 (84)102 (95)Missing values: Gender, *N* = 37; residency, *N* = 69; age, *N* = 142

Overall results based on case definitions {#Sec8}
-----------------------------------------

As per case definition, malaria positivity was found in 17% (268/1564), dengue in 16% (244/1564), scrub typhus in 10% (159/1564), bacteraemia in 8% (124/1564), leptospirosis in 7% (116/1564) and chikungunya in 6% (98/1564). Among malaria cases, 54% (145/268) were *Plasmodium falciparum.* Details of malaria results in this study have been reported previously \[[@CR7]\]. Among bacteraemia cases, *Salmonella typhi* or *S. paratyphi* constituted 35% (44/124), *Staphylococcus aureus* 19% (24/124), *E. coli* 9% (11/124) and *Streptococcus pneumoniae* 6% (7/124).

Centre-wise aetiologies {#Sec9}
-----------------------

Table [2](#Tab2){ref-type="table"} shows prevalence of each aetiology at the different hospitals.Table 2Aetiology based on standard diagnostic tests grouped by age and study site. *N* = 1564DiagnoseTotal *N* = 15645--14 years *N* = 19915--59 years *N* = 1069\>60 years *N* = 154Oddanchatram *N* = 330Ambur *N* = 316Tezpur *N* = 336Mungeli *N* = 62Anantapur *N* = 160Ratnagiri *N* = 251Raxaul *N* = 109Malaria PCR Positive268 (17)26 (13)201 (19)23 (15)19 (6)44 (14)49 (15)13 (21)28 (18)85 (34)30 (28) Negative1144 (73)151 (76)773 (72)126 (82)299 (91)230 (73)244 (73)39 (63)96 (60)160 (64)76 (70)Malaria microscopy + PCR Positive66 (4)4 (2)57 (5)4 (3)3 (1)7 (2)14 (4)2 (3)9 (6)29 (12)2 (2) Negative1102 (70)123 (62)667 (62)101 (66)315 (95)110 (35)262 (78)5 (8)104 (65)208 (83)98 (90)Bacteraemia Positive124 (8)13 (7)102 (10)4 (3)31 (9)9 (3)36 (11)014 (9)13 (5)21 (20) Negative^a^1037 (66)136 (68)691 (65)108 (70)297 (90)300 (95)12 (3)5 (8)98 (61)214 (85)80 (73)Dengue Positive^b^244 (16)3 (2)39 (4)1 (1)25 (8)59 (19)19 (6)3 (5)54 (34)76 (30)8 (7) Negative^c^1243 (79)121 (61)694 (65)97 (63)305 (92)252 (78)292 (87)30 (48)95 (59)170 (68)99 (91)Scrub typhus Positive^d^159 (10)26 (13)113 (11)15 (10)7 (2)35 (11)75 (22)1 (2)5 (3)20 (8)16 (15) Negative^e^1281 (82)155 (80)879 (86)130 (86)307 (93)267 (84)220 (65)32 (52)147 (92)217 (86)91 (83)Leptospirosis Positive^f^116 (7)6 (3)95 (9)13 (8)6 (2)14 (4)49 (15)2 (3)14 (9)26 (10)5 (5) Negative^g^1303 (83)167 (84)865 (81)121 (79)314 (95)292 (92)232 (69)29 (47)132 (83)209 (83)95 (87)Chikungunya Positive98 (6)17 (9)71 (7)8 (5)33 (10)15 (5)4 (1)029 (18)13 (5)4 (4) Negative1389 (89)170 (85)955 (89)142 (92)284 (86)296 (94)308 (92)34 (55)124 (76)238 (95)105 (96)Data are given as number and percentages among total of patients with case definitions filled, including those with more than one case definition. Discrepancies between positive plus negative results and total number are due to missing values or inconclusive/discrepant test results^a^Including contaminants (*N* = 40). ^b^Positive MAC ELISA and/or RDT. ^c^Negative MAC ELISA and/or RDT. ^d^Positive IFA on ELISA positives. ^e^ELISA negatives and positive ELISA/IFA negatives. ^f^Positive MAT on ELISA positives. ^g^ELISA negatives and ELISA positive/MAT negatives

The highest prevalence of malaria was found in West-, North- and Central India (Ratnagiri 34%, Raxaul 28% and Mungeli 21%). The highest prevalence of dengue was found in South- and West India (Anantapur 34%, Ambur 19% and Ratnagiri 30%), and a high prevalence of chikungunya (18%) was also found in Anantapur. The highest prevalence of scrub typhus was found in North- and North East India (Tezpur 22% and Raxaul 15%). Tezpur also had the highest prevalence of leptospirosis (15%). Raxaul in North India had as high prevalence as 20% of bacteraemia.

Overlapping aetiologies {#Sec10}
-----------------------

More than one case definition was found in a high number of patients. The overlap between diagnoses is shown in detail in Table [3](#Tab3){ref-type="table"}. The largest overlap was found in chikungunya, where 57% (56/98) had one or more additional case definition and 26% (25/98) overlapped with dengue. Malaria was found in 20% (25/124) among patients with bacteraemia, and among these 48% (12/25) was *P. falciparum*. Among patients with *P. falciparum* and bacteraemia, *Staphylococcus aureus* or Enterobacteriacae including *Salmonella typhi* and *S. paratyphi* were identified. Among patients with positive malaria microscopy confirmed by PCR, 5% (3/66) had bacteraemia.Table 3Overlap between case definitions (*N* = 1564)Tot *N*Lepto spirosis *N* (%)Scrub typhus *N* (%)Dengue *N* (%)Chikungunya *N* (%)Bacteraemia *N* (%)Malaria *N* (%)Two or more case def. *N* (%)Leptospirosis116--28 (24)16 (14)9 (8)14 (12)24 (21)55 (47)Scrub typhus15928 (18)--20 (13)13 (8)10 (6)27 (17)61 (38)Dengue24416 (7)20 (8)--25 (10)13 (5)58 (24)95 (39)Chikungunya989 (9)13 (13)25 (26)--7 (7)20 (20)56 (57)Bacteraemia12414 (11)10 (8)13 (5)7 (6)--25 (20)41 (33)Malaria26824 (9)27 (10)58 (22)20 (7)25 (9)--119 (44)  *P. falciparum*11611 (9)17 (15)33 (28)8 (7)12 (10)--Lepto + Scrub28----5 (18)3 (11)5 (18)5 (18)Lepto + Dengue16--5 (31)--1 (6)3 (19)4 (25)Lepto + Chik9--3 (33)1 (11)--01 (11)Lepto + Bact14--5 (36)3 (21)0--4 (29)Scrub + Dengue205 (25)----2 (10)1 (5)4 (20)Scrub + Chik133 (23)--2 (15)--03 (23)Scrub + Bact105 (50)--1 (10)0--4 (40)Chik + Bact7002----1Bact + Dengue400--0--2Lepto + Scrub + Dengue5------111Scrub + Deng + Mal41----10--Scrub + Bact + Mal42--000Dengue + Chik + Mal201----1--Data are given as number of patients and percentages

The association between positive serology (dengue, leptospirosis, scrub typhus and chikungunya) and malaria and septicaemia is shown in Table [4](#Tab4){ref-type="table"}. For each of the four aetiologies, positive serology was equally or more prevalent among malaria positive than negative patients. This was still the case when considering the stricter case definition of clinical malaria, microscopy confirmed by PCR, possibly reducing any bias caused by asymptomatic low parasitaemia. For bacteraemia, the picture was more heterogeneous, where the prevalence of dengue was higher among culture-negative than bacteraemic patients.Table 4Serology associated with malaria and bacteraemiaSerology*N*Malaria PCR (*n* = 1412)Malaria PCR + microscopy (*N* = 984)Bacteraemia (*N* = 1161)Positive *N* = 268\
*N* (%)Negative *N* = 1144\
*N* (%)*P*Positive *N* = 66Negative *N* = 918*P*Positive *N* = 124Negative^i^ *N* = 1037*P*Dengue Positive^a^24458/258 (22)170/1118 (15)0.00513/65 (20)120/908 (13)0.12413/124 (10)197/1021 (19)0.017 Negative^b^1243200/258 (78)948/1118 (85)52/65 (80)788/908 (87)111/124 (90)824/1021 (81)Leptospirosis Positive^c^11624/248 (10)85/1061 (8)0.3937/60 (12)72/853 (8)0.39014/118 (12)57/985 (6)0.011 Negative^d^1303224/248 (90)976/1061 (92)53/60 (88)781/853(92)104/118 (88)928/985 (94)Scrub typhus Positive^e^15927/250 (11)119/1078 (11)0.91310/63 (16)104/872 (12)0.35510/118 (8)76/989 (8)0.762 Negative^f^1281223/250 (89)959/1078 (89)53/63 (84)768/872 (88)108/118 (92)913/989 (92)Chikungunya Positive^g^9820/261 (8)70/1117 (6)0.4115/64 (8)57/904 (6)0.6347/123 (6)82/1020 (8)0.359 Negative^h^1389241/261(92)1047/1117(94)59/64 (92)847/904 (94)116/123(94)938/1020 (92)Data are given as numbers and percentages of tests among total tested with both methods. Discrepancies in numbers are due to missing values. Chi-Square test used for comparison of proportions^a^Positive MAC ELISA and/or RDT. ^b^Negative MAC ELISA/RDT. ^c^Positive ELISA and MAT. ^d^Negative ELISA and positive ELISA/negative MAT. ^e^Positive ELISA and IFA. ^f^Negative ELISA and positive ELISA/negative IFA. ^g^Positive ELISA. ^h^Negative ELISA ^i^Including 40 samples with contaminants

Performance of test systems {#Sec11}
---------------------------

Table [5](#Tab5){ref-type="table"} shows the test results of routine diagnostic tests and assesses their performance compared to reference methods.Table 5Results of tests and performance of routine diagnostic methods compared to reference tests. *N* = 1564Diagnostic method*N*Positive *N* (%)Negative *N* (%)Equivocal or discrepancy^a^ *N* (%)Missing data *N*Leptospira ELISA1502201 (14)1240 (83)61 (4)62 MAT on ELISA positives179116 (65)63 (35)22 MAT on ELISA negatives5232 (62)20 (38)1188Scrub typhus ELISA1504313 (21)1180 (78)11 (1)60 IFA on ELISA positives260159 (61)101 (39)53 IFA on ELISA negatives10712 (11)95 (89)1073Dengue NS1/IgM/IgG Combo (RDT)1465124 (8)1318 (90)23 (2)99 MAC ELISA1400177 (13)1064 (76)159 (11)164 RDT and/or MAC ELISA1501244 (16)1243 (83)14 (1)63 MAC ELISA on RDT positives11857 (48)48 (41)13 (11)6 MAC ELISA on RDT negatives1225102 (8)989 (81)134 (11)93Chikungunya ELISA148798 (7)1389 (93)77Blood culture1161164 (14)997 (86)403 Pathogenic1161124 (11)   *Neisseria* spp.1241 (1)   *S. aureus*12424 (19)   *Enterococci* spp.1242 (2)   *E. faecalis*1241 (1)   *S. pneumoniae*1247 (6)   *S. pyogenes*1241 (1)   *Streptococci* spp.1241 (1)   *S. typhi/paratyphi*12444 (35)   *Klebsiella* spp1241 (1)   *E. coli*12411 (9)   *Enterobacter spp*1241 (1)   *Acinetobacter*1244 (3)   *Burkholderia cepacia*1241 (1)   *Pseudomonas* spp1241 (1)   *Proteus*1242 (2)  Unidentified^b^12422 (18) Contaminants^c^116140 (3)Malaria Genus specific PCR1412268 (19)1144 (81)152 Species PCR or sequencing25117   *P. falciparum*251116 (46)   *P. vivax*25196 (38)   *P. malariae*2519 (4)   *P. falciparum + vivax*25127 (11)   *P. falciparum + malariae*2512 (1)   *P. vivax + malariae*2511 (0.4) Microscopy126396 (8)1167 (92)301 Microscopy and genus PCR116866 (6)918 (79)184 (16)396 Microscopy, genus PCR and RDT116341 (4)906 (78)216 (19)401^a^Discrepancy between tests performed at study sites and reference laboratory, or equivocal results^b^Cocci (*N* = 5), gram negative (*N* = 4), gram positive (*N* = 7), unidentified (*N* = 6)^c^ *Bacillus* (*N* = 14), coagulase negative staphylococci (*N* = 7), *Corynebacterium* (*N* = 4), diphteroids (*N* = 1), micrococci (*N* = 10), undefined contaminants (*N* = 4)

Using IFA as gold standard, positive predictive value for Scrub typhus IgM ELISA was 61% (159/260), and negative predictive value was 89% (95/107).

Compared to MAT, positive predictive value for *Leptospira* IgM ELISA was 65% (116/179) while negative predictive value was as low as 38% (20/52). The study was not designed to evaluate sensitivity and specificity, as gold standard tests were not performed on all ELISA negatives.

Using malaria PCR as gold standard, the sensitivity of routine microscopy was 29% (66/228) and RDT 24% (65/268), as reported previously \[[@CR7]\].

Sensitivity and specificity for dengue tests were not calculated because gold standard was positive RDT and/or MAC ELISA, and the two tests are expected to be positive during different intervals of the illness. Indeed, only 46% (57/124) of RDT positives were positive by MAC ELISA, probably reflecting early infections detected only by NS1Ag.

Discussion {#Sec12}
==========

This study of aetiology of undifferentiated fever in rural India using standard diagnostic tests, revealed a high prevalence of malaria and dengue. However, there was a strikingly high prevalence of overlap of case definitions. An overlap with one or more other case-definition was found for all diagnosed diseases, ranging from 33% (bacteraemia) to 57% (chikungunya) (Table [3](#Tab3){ref-type="table"}). The highest frequency of overlap was found in chikungunya where dengue was simultaneously diagnosed in 26% (25/98), followed by leptospirosis, where scrub typhus was found in 24% (28/116).

Cross reactivity, or background positivity due to previous infections, are well known limitations of serological tests, and fourfold rise of titer in convalescence samples or a high acute phase titer is recommended to confirm a diagnosis. Convalescent samples were not available in this study, reflecting a real life situation in resource poor settings where tests for follow up in recovered patients are usually not collected.

Detecting a pathogen directly by PCR or culture is more specific than indirect diagnosis by antibody detection, and the diagnoses of malaria and bacteraemia are therefore likely to be more specific than leptospirosis, scrub typhus, chikungunya and dengue in this study. Positive serological tests for dengue, leptospirosis, scrub typhus and chikungunya were common also in patients with malaria and bacteraemia (Table [4](#Tab4){ref-type="table"}), suggesting low specificity of the serological tests. Although coinfections are possible, it is more likely that multiple fulfilled case definitions in a high proportion of patients are due to cross reactivity and background positivity, reflecting that the diseases detected by serology are endemic in the area, rather than high prevalence of coinfections. The findings in the present study emphasises the importance of interpreting diagnostic tests in a clinical context together with symptoms, clinical findings and biochemical tests.

Malaria {#Sec13}
-------

Malaria parasites were detected by PCR in 17% (268/1564) among patients included, and among these 54% (145/268) were *P. falciparum*, as reported previously \[[@CR7]\]. Due to high sensitivity of malaria PCR compared to microscopy and RDT, some PCR positive cases may potentially have had asymptomatic low parasitemia controlled by immunity, or recently been treated for malaria, and their fever caused by another infection \[[@CR7], [@CR9]\]. As reported previously, microscopy had low sensitivity (29%, 66/228) but high specificity (98%, 918/940) compared to PCR, and a very strict case definition of clinical malaria as cause of acute fever can be defined as a positive microscopy confirmed by PCR \[[@CR7]\]. The prevalence of malaria by microscopy confirmed by PCR was 6% (66/1168).

Bacteraemia {#Sec14}
-----------

Blood stream infection with pathogenic bacteria was diagnosed in 8% (124/1564), and among these *Salmonella typhi* or *S. paratyphi* were found in 35% (44/124), reflecting the high prevalence of enteric fever in India. Enteric fever is closely associated with poor sanitation, lack of safe water supply and treatment failures due to antimicrobial resistance and is still reported as the most common blood stream infection in India and in South Asia \[[@CR10]--[@CR13]\]. The second most common microbe identified was *S. aureus* (19% 24/124), followed by *E.-coli* (9%, 11/124) and *S. pneumoniae* (6%, 7/124).

Dengue {#Sec15}
------

Dengue and severe dengue because of immune enhancement due to a previous infection with another serotype is an increasing problem in India \[[@CR14], [@CR15]\]. India is estimated to contribute 34% (33/96 million) of the total global burden of dengue \[[@CR16]\], with increasing incidence both of dengue and outbreaks of severe dengue \[[@CR17], [@CR18]\]. The risk of severe dengue is high, as more than 25% of the population in Delhi has been reported to have had a past infection \[[@CR17], [@CR19]\]. In line with the high prevalence reported in previous studies, dengue was found in as much as 16% (244/1564) in the present study, highest in the sites in South- and West India.

Rapid tests combining detection of non-structural protein 1 (NS1) antigen and IgM/IgG are used in routine diagnostics, as they have high sensitivity both during the viremic early phase of infection when NS1 is produced and after more than five days when IgM can be detected \[[@CR20]\]. IgM capture ELISA (MAC ELISA) is used as reference method, but is less sensitive than NS1Ag until day five of infection. Case definition used in the present study was therefore a positive test with RDT and/or ELISA, in order not to miss out early infections detected by NS1Ag. However, background positivity is a potential limitation since MAC ELISA can be positive for several months after infection \[[@CR21]\]. Although NS1 antigen is less prone to give cross reactivity than IgM antibodies, combination tests have shown some false positive reactions in non-dengue infections, most commonly in chikungunya \[[@CR20], [@CR21]\].

Chikungunya {#Sec16}
-----------

A large outbreak of *Chikungunya* was reported in Ahmedabad in India in 2006 \[[@CR22]\]. Sharing the same vector, chikungunya is likely to occur during dengue outbreaks, and in a study during a dengue outbreak in Delhi in 2010, 10% (66/666) positive chikungunya cases were diagnosed among dengue IgM negative fever patients \[[@CR23]\]. Sporadic outbreaks of chikungunya has been reported in India since 1963, in 2006 affecting 13 states with 1.4 million suspected cases \[[@CR23]\], with high numbers in Andhra Pradesh, Tamil Nadu and Maharashtra. This supports the finding in the present study of highest prevalence of chikungunya in Anantapur (Andhra Pradesh), Oddanchatram and Ambur (Tamil Nadu) and Ratnagiri (Maharashtra).

Leptospirosis {#Sec17}
-------------

Leptospirosis is transmitted by urine from infected animals (rats, cattle, pigs) and is endemic particularly in the Andaman and Nicobar group of islands ("Andaman haemorrhagic fever") \[[@CR24]\]. In AUF studies from South- and Northern India, leptospirosis was reported in 3% and 0.1% respectively \[[@CR11], [@CR12]\]. In the present study leptospirosis was found in 7% (116/1564), and cases were identified at all study sites.

Culturing *Leptospira* is unreliable, and the gold standard is therefore serology confirmed by MAT. MAT detects IgM and IgG antibodies against a pool of live antigens from different *Leptospira* serovars. A MAT titer \>100 is considered positive, but a fourfold rise in convalescence titer or a high single acute phase titer (\>200--1600 depending on endemicity) supports the diagnosis \[[@CR25]\]. Following acute leptospirosis, both IgM ELISA and MAT remain positive for several years after infection, with duration differing between serogroups \[[@CR26]\]. In one prospective study from Barbados, positive MAT was found up to 11 years after infection, with highest prevalence after serogroup Autumnalis infection where 20% had MAT titer \>800 after four years \[[@CR26]\]. In the present study Autumnalis was found in 7%. Leptospira serovar prevalence and distribution in this study has been reported previously \[[@CR27]\]. *Leptospira* IgM ELISA has been reported positive in 40% and 5% one and six years after infection respectively \[[@CR26]\]. Discrimination between acute and previous infection in the present study is limited by lack of convalescent samples, and a low MAT cut-off titer of 100. However, high prevalence of antibodies in all study sites suggests that the disease is endemic in the areas.

Scrub typhus {#Sec18}
------------

Scrub typhus is transmitted by mites who live on rats. The disease is, similar to leptospirosis, associated with agricultural work and rural dwelling \[[@CR28]\]. Two studies have reported prevalence of 14% and 47% among hospitalized febrile patients in North- and South India respectively \[[@CR11], [@CR12]\]. The disease is endemic in various parts of India, but underreported \[[@CR1], [@CR29]--[@CR35]\]. In the present study, scrub typhus was found in 10% (159/1564), and the disease was identified at all study sites.

Serology confirmed by IFA, ideally confirmed by rise of titer in convalescent samples and/or by cut-off values based on endemicity, remains the mainstay of diagnostics since isolation of the bacteria is not possible and PCR from blood has low sensitivity \[[@CR36]\]. Sensitivity of IFA may be influenced by antigen variation. Usually antigens from three serotypes (Karp, Kato and Gilliam) are used, while additional antigens may be present in different areas \[[@CR30], [@CR36]\]. In the present study, discrimination between previous scrub typhus and acute infection is limited by the lack of convalescent samples. Also an optic density (OD) value of 0.5 may be in the lower range and, thereby, in some cases reflect background positivity.

Potential coinfections {#Sec19}
----------------------

Although background positivity or cross reactivity in serology, and potential subclinical infections in malaria, may have given positive test results in some cases, some of the overlapping aetiologies have probably been due to true clinically relevant coinfections.

Coinfections could occur principally by two different mechanisms; by contracting multiple infections at the same time, or increased pathogenicity of a simultaneous subclinical infection due to immune reactions.

The risk of bacterial sepsis is increased in severe malaria, through immune mediated barrier dysfunction in the gut and bacterial translocation, as well as IL-10 mediated decreased control of bacteraemia \[[@CR37], [@CR38]\]. In clinical studies, invasive infection, frequently with *Salmonella* spp. or other Gram-negatives, are found both in *P. falciparum* and *P. vivax* malaria \[[@CR39], [@CR40]\], which supports the finding of as much as 9% (25/268) bacteraemia among malaria patients in the present study. On the other hand, asymptomatic malaria controlled by immunity may obscure correct diagnosis of bacterial sepsis \[[@CR41]--[@CR43]\], and an undefined proportion of the malaria positive patients among those with bacteraemia may have had subclinical malaria in the present study.

In a study among Thai rice farmers with leptospirosis diagnosed with 4-fold rise in titer or a single high titer, as many as nine among 22 patients had coinfection with scrub typhus confirmed by serology and eschar or clinical characteristics \[[@CR44]\]. Although a very high overlap between positive tests for scrub typhus and leptospirosis in the present study suggests background positivity or cross reactivity, a proportion of the patients may have had coinfections taking into consideration the similar exposure risk.

True coinfections with malaria and scrub typhus, diagnosed by clinical characteristics and eschar or PCR, have also been reported in India \[[@CR45]--[@CR47]\]. However, the high level of positive scrub typhus serology in single samples found in other Indian studies \[[@CR12], [@CR48]\], raises the same question as in the present study where 10% (27/268) of malaria cases had positive scrub typhus serology, do the results reflect true coinfections, or cross reactivity or background positivity?

In the mosquito borne infections dengue, malaria and chikungunya, outbreaks occur during rainy seasons and although the specific vector is different for malaria, coinfections are not unlikely. This was shown in a study from India during a dengue outbreak, where 7% (27/367) of dengue cases had coinfection with malaria \[[@CR49]\]. As much as 22% (58/268) of malaria cases had positive dengue tests in the present study (Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}).

A high level of coinfections with dengue and chikungunya was shown during a dengue outbreak in Delhi in 2006 using PCR as the method for detection. Among 17 chikungunya positive patients, six were co-infected with dengue virus \[[@CR50]\]. Ten percent coinfection was found in a study from Mumbai \[[@CR51]\]. Dengue and chikungunya virus share a common mosquito vector, the daytime biting *Aedes aegypti* and *A. albopictus*, and are present in similar geographical regions. In the present study, dengue and chikungunya both had high prevalence in Anantapur, supporting the notion that coinfections as well as cross reactivity could explain some overlap between dengue and chikungunya.

Conclusion {#Sec20}
==========

A high prevalence of malaria and dengue, and a high overlap between case definitions were found in this study. The overlap probably reflects an undefined level of previous infections, cross reactivity and subclinical infections in the population, rather than high prevalence of coinfections. These limitations of routine diagnostic tests should be taken into consideration when approaching the patient with acute undifferentiated fever in India.

AUF

:   Acute Undifferentiated Fever

CMC

:   Christian Medical College

ELISA

:   Enzyme-linked immunosorbent assay

IFA

:   Immunofluorescence assay

IL-10

:   Interleukin 10

MAC-ELISA

:   IgM Antibody Capture ELISA

MAT

:   Microscopic Agglutination Test

NIV

:   National Institute of Virology

NS1

:   Non-structural protein 1

OD

:   Optical Density

PCR

:   Polymerase Chain Reaction

RDT

:   Rapid Diagnostic Test
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